about
Blood pressure demographics: nature or nurture ... ... genes or environment?Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension.Homozygosity by descent mapping of blood pressure in the Old Order Amish: evidence for sex specific genetic architectureMicrosatellites and SNPs linkage analysis in a Sardinian genetic isolate confirms several essential hypertension loci previously identified in different populationsThe Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans.Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population.Multiple genes for essential-hypertension susceptibility on chromosome 1q.Genetic effect on blood pressure is modulated by age: the Hypertension Genetic Epidemiology Network Study.Association of AT1R polymorphism with hypertension risk: An update meta-analysis based on 28,952 subjects.Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis.Molecular genetics of essential hypertension.Animal models for the study of primary and secondary hypertension in humans.Opportunities and limitations of genetic analysis of hypertensive rat strains.Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.Association of eNOS gene polymorphism (rs3918166) with blood pressure in adult Japanese.Association of polymorphisms in prolylcarboxypeptidase and chymase genes with essential hypertension in the Chinese Han population.Angiotensin II type 1 receptor gene polymorphism and telomere shortening in essential hypertension.Muscle sympathetic response to arousal predicts neurovascular reactivity during mental stress.Genome-wide linkage analysis of hemodynamic parameters under mental and physical stress in extended Omani Arab pedigrees: the Oman Family Study.Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran.
P2860
Q24803842-9B2CC397-84B4-4F5C-AE53-890726A8FACBQ30385528-045A6604-9E6A-46F8-ACD6-EA6E29F8D063Q33301057-5F0175C0-E44D-4887-AF25-0DA5862C05C8Q33498133-25ADA0F5-B434-4686-8AF2-F3A4E6A1C3CDQ33664406-41CBEA14-1E17-4C7A-935D-FFA94A9AB43AQ33745223-2E27C91E-559B-47A1-8AD1-91CC4A883464Q35616722-86E9AD30-8BA9-494F-B05C-D339E2F456B5Q37079524-F80B6258-95D1-4C90-8C39-1A04ACD14479Q38389878-6CC76A64-A53D-4351-A7AD-4FBA92674E29Q38431168-4E7A134B-9648-43C4-A3C4-9BBB99F8B4EFQ38793780-5BFE400B-ADCE-4A0A-AADA-877C4362220AQ39095951-206B6541-D8C6-4852-937E-7CA9028FD752Q42571400-F81656CB-DDD8-419B-BFDF-6CD456E9328AQ43547068-5313C551-47AC-4B2D-ACF2-01EC3F6FAF07Q44686483-A266EE35-F145-4712-8509-F7FC6E45E018Q44990169-657E79F1-523E-4AD8-BE9D-524C28608327Q46940912-B32B245F-09EF-40EF-855A-4133E62B8F28Q50760471-3DE72339-5F85-4FB8-8E48-9A19EE4778DDQ50800560-1FBA49B6-1AC2-421B-AB76-ED941500EE0AQ51496434-560ADA12-8E4A-489B-9C0C-9A99F983718CQ54331504-BD8C5113-FD93-4B27-A918-025410EB6717
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genes and hypertension.
@ast
Genes and hypertension.
@en
type
label
Genes and hypertension.
@ast
Genes and hypertension.
@en
prefLabel
Genes and hypertension.
@ast
Genes and hypertension.
@en
P2093
P356
P1476
Genes and hypertension.
@en
P2093
E A Garcia
M J Caulfield
P B Munroe
S Newhouse
P304
P356
10.2174/1381612033454513
P577
2003-01-01T00:00:00Z